| pubmed-article:12100701 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12100701 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12100701 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:12100701 | lifeskim:mentions | umls-concept:C0033860 | lld:lifeskim |
| pubmed-article:12100701 | lifeskim:mentions | umls-concept:C0055895 | lld:lifeskim |
| pubmed-article:12100701 | lifeskim:mentions | umls-concept:C0599724 | lld:lifeskim |
| pubmed-article:12100701 | lifeskim:mentions | umls-concept:C0991510 | lld:lifeskim |
| pubmed-article:12100701 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:12100701 | pubmed:dateCreated | 2002-7-8 | lld:pubmed |
| pubmed-article:12100701 | pubmed:abstractText | Topical corticosteroids are the primary treatment for mild to moderate psoriasis. Foam preparations of corticosteroids offer potential cosmetic and pharmacodynamic advantages over cream and ointment vehicles. A clobetasol propionate foam product is as effective as clobetasol propionate solution in the treatment of scalp psoriasis. | lld:pubmed |
| pubmed-article:12100701 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12100701 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12100701 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12100701 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12100701 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12100701 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12100701 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12100701 | pubmed:month | May | lld:pubmed |
| pubmed-article:12100701 | pubmed:issn | 0011-9059 | lld:pubmed |
| pubmed-article:12100701 | pubmed:author | pubmed-author:MenterAlanA | lld:pubmed |
| pubmed-article:12100701 | pubmed:author | pubmed-author:WashenikKenK | lld:pubmed |
| pubmed-article:12100701 | pubmed:author | pubmed-author:LebwohlMarkM | lld:pubmed |
| pubmed-article:12100701 | pubmed:author | pubmed-author:FeldmanSteven... | lld:pubmed |
| pubmed-article:12100701 | pubmed:author | pubmed-author:KruegerGerald... | lld:pubmed |
| pubmed-article:12100701 | pubmed:author | pubmed-author:KooJohnJ | lld:pubmed |
| pubmed-article:12100701 | pubmed:author | pubmed-author:ShererDanielD | lld:pubmed |
| pubmed-article:12100701 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12100701 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:12100701 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12100701 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12100701 | pubmed:pagination | 269-74 | lld:pubmed |
| pubmed-article:12100701 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:meshHeading | pubmed-meshheading:12100701... | lld:pubmed |
| pubmed-article:12100701 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12100701 | pubmed:articleTitle | A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis. | lld:pubmed |
| pubmed-article:12100701 | pubmed:affiliation | Departments of Dermatology, Mount Sinai Medical Center, New York, NY 10029-6574, USA. sinaiderom@aol.com | lld:pubmed |
| pubmed-article:12100701 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12100701 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12100701 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:12100701 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12100701 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12100701 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12100701 | lld:pubmed |
